chrX-47169434-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_ModerateBP6_ModerateBS2
The NM_005676.5(RBM10):c.137G>A(p.Arg46His) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,210,380 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R46C) has been classified as Uncertain significance.
Frequency
Consequence
NM_005676.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RBM10 | NM_005676.5 | c.137G>A | p.Arg46His | missense_variant | 3/24 | ENST00000377604.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RBM10 | ENST00000377604.8 | c.137G>A | p.Arg46His | missense_variant | 3/24 | 1 | NM_005676.5 | A1 | |
RBM10 | ENST00000329236.8 | c.332G>A | p.Arg111His | missense_variant | 3/24 | 1 | P3 | ||
RBM10 | ENST00000628161.2 | c.137G>A | p.Arg46His | missense_variant | 3/23 | 1 | |||
RBM10 | ENST00000345781.10 | c.137G>A | p.Arg46His | missense_variant | 3/23 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112567Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34735
GnomAD3 exomes AF: 0.0000550 AC: 10AN: 181869Hom.: 0 AF XY: 0.0000903 AC XY: 6AN XY: 66445
GnomAD4 exome AF: 0.0000200 AC: 22AN: 1097813Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 9AN XY: 363183
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112567Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34735
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at